Ballentine Partners, LLC PACB — PACIFIC BIOSCIENCES CALIF IN

Ownership history in Ballentine Partners, LLC  ·  21 quarters on record

AI Ownership Summary

Ballentine Partners, LLC reported PACIFIC BIOSCIENCES CALIF IN (PACB) in 21 quarterly 13F filings from 2024 Q3 through 2026 Q2. The latest visible filing shows PACB at 0.00% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this PACB ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Ballentine Partners, LLC's position in PACIFIC BIOSCIENCES CALIF IN, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q2

PACB was reported at 0.00% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.0% in 2024 Q4

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q3 to 2026 Q2

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

PACB stock page Ballentine Partners, LLC fund profile Ballentine Partners, LLC full holdings
How Ballentine Partners, LLC held PACB — position size vs. price
% of Fund (quarterly)    PACB price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 8 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q2 REDUCED — — — 14,386 -2,277 -13.7% 0.00% $24K 2026-07-17 $1.44
2026 Q1 REDUCED 20.0% +31.1% ❌ 16,663 -4,160 -20.0% 0.00% $22K 2026-05-14 $1.21
2025 Q4 ADDED — — — 20,823 +4,342 +26.3% 0.00% $39K 2026-02-03 $2.04
2025 Q3 REDUCED — — — 16,481 -359 -2.1% 0.00% $21K 2025-11-03 $2.24
2025 Q2 REDUCED 11.5% +0.8% ❌ 16,840 -2,179 -11.5% 0.00% $21K 2025-07-15 $1.44
2025 Q1 REDUCED 34.8% +5.1% ❌ 19,019 -10,133 -34.8% 0.00% $22K 2025-05-01 $1.11
2024 Q4 ADDED — — — 29,152 +3,845 +15.2% 0.00% $53K 2025-01-16 $1.60
2024 Q3 ADDED — — — 25,307 +14,059 +125.0% 0.00% $43K 2024-10-23 $1.75
13 older quarters hidden  —  Sign in free or upgrade to Premium to see full history

🏢 Other funds also holding PACB

As of 2026 Q2 — sorted by position size

Koa Wealth Management, LLC 0.14% Mirador Capital Partners LP 3Y 7Y 0.07% KAVAR CAPITAL PARTNERS GROUP, LLC 3Y 0.02% NJ State Employees Deferred Compensation Plan 3Y 7Y 0.01% Abacus Planning Group, Inc. 3Y 7Y 0.01% FNY Investment Advisers, LLC 3Y 7Y 0.01% Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors 3Y 7Y 0.0% IFP Advisors, Inc 3Y 7Y 0.0% Fortitude Family Office, LLC 0.0% Sequoia Financial Advisors, LLC 3Y 7Y 0.0%

FAQ About Ballentine Partners, LLC and PACB

These are the practical questions this page is built to answer before you even open the full history table.

How long has Ballentine Partners, LLC reported owning PACB?

Ballentine Partners, LLC reported PACB across 8 quarterly 13F filings, from 2024 Q3 through 2026 Q2.

What was the largest reported PACB position in Ballentine Partners, LLC's portfolio?

The largest reported portfolio weight for PACB was 0.00% in 2024 Q4.

What is the latest reported PACB position on this page?

The most recent filing on this page is 2026 Q2, when Ballentine Partners, LLC reported 14,386 shares, equal to 0.00% of portfolio, with an estimated market value of $24K.

What does the chart on this PACB ownership page compare?

The chart compares Ballentine Partners, LLC's quarterly PACB portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did Ballentine Partners, LLC time their PACB position?

Based on 13F filing dates vs. subsequent PACB price moves, Ballentine Partners, LLC correctly timed 8 out of 20 reported position changes (40%). The annualised alpha on PACB relative to SPY over the holding period was -25.5%.

← Back to Ballentine Partners, LLC Holdings